We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stocks Picks with Huge Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical Inc.

Learn more about whether Alvotech or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Sei Investments Co. trimmed its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 15.4% in ...

KLP Kapitalforvaltning AS acquired a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) during the 4th quarter, according to its most recent filing with the Securities and ...

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) tops our list for being one of the best genomic stocks. It focuses on developing and commercializing treatments for genetic diseases. Its product ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Ultragenyx Pharmaceutical Inc.

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Alongside the funding announcement, Epicrispr has welcomed new members, including Andrew Lam from Ally Bridge Group, Intellia Therapeutics Business Development former senior vice-president Jennifer ...